176 related articles for article (PubMed ID: 26941401)
1. UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells.
Samudio I; Rezvani K; Shaim H; Hofs E; Ngom M; Bu L; Liu G; Lee JT; Imren S; Lam V; Poon GF; Ghaedi M; Takei F; Humphries K; Jia W; Krystal G
Blood; 2016 May; 127(21):2575-86. PubMed ID: 26941401
[TBL] [Abstract][Full Text] [Related]
2. UV Light-inactivated HSV-1 Stimulates Natural Killer Cell-induced Killing of Prostate Cancer Cells.
Samudio I; Hofs E; Cho B; Li M; Bolduc K; Bu L; Liu G; Lam V; Rennie P; Jia W; Elisia I; Krystal G
J Immunother; 2019 Jun; 42(5):162-174. PubMed ID: 30933043
[TBL] [Abstract][Full Text] [Related]
3. NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors.
Wang Y; Jin J; Li Y; Zhou Q; Yao R; Wu Z; Hu H; Fang Z; Dong S; Cai Q; Hu S; Liu B
Transl Res; 2022 Feb; 240():64-86. PubMed ID: 34757194
[TBL] [Abstract][Full Text] [Related]
4. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction.
Ahmad A; Sharif-Askari E; Fawaz L; Menezes J
J Virol; 2000 Aug; 74(16):7196-203. PubMed ID: 10906173
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL
J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
7. Reovirus activates human dendritic cells to promote innate antitumor immunity.
Errington F; Steele L; Prestwich R; Harrington KJ; Pandha HS; Vidal L; de Bono J; Selby P; Coffey M; Vile R; Melcher A
J Immunol; 2008 May; 180(9):6018-26. PubMed ID: 18424722
[TBL] [Abstract][Full Text] [Related]
8. Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.
Uyangaa E; Choi JY; Patil AM; Hossain FMA; Park SO; Kim B; Kim K; Eo SK
Front Immunol; 2018; 9():905. PubMed ID: 29760708
[TBL] [Abstract][Full Text] [Related]
9. Functional paralysis of human natural killer cells by alphaherpesviruses.
Campbell TM; McSharry BP; Steain M; Russell TA; Tscharke DC; Kennedy JJ; Slobedman B; Abendroth A
PLoS Pathog; 2019 Jun; 15(6):e1007784. PubMed ID: 31194857
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study.
Fawaz LM; Sharif-Askari E; Menezes J
J Immunol; 1999 Oct; 163(8):4473-80. PubMed ID: 10510389
[TBL] [Abstract][Full Text] [Related]
11. NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.
Moraru M; Black LE; Muntasell A; Portero F; López-Botet M; Reyburn HT; Pandey JP; Vilches C
J Immunol; 2015 Aug; 195(4):1676-84. PubMed ID: 26179905
[TBL] [Abstract][Full Text] [Related]
12. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
13. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
14. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
15. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.
Seay K; Church C; Zheng JH; Deneroff K; Ochsenbauer C; Kappes JC; Liu B; Jeng EK; Wong HC; Goldstein H
J Virol; 2015 Jun; 89(12):6264-74. PubMed ID: 25833053
[TBL] [Abstract][Full Text] [Related]
17. Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors.
Fitzgerald-Bocarsly P; Feldman M; Mendelsohn M; Curl S; Lopez C
J Leukoc Biol; 1988 Apr; 43(4):323-34. PubMed ID: 2832497
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.
Linn YC; Hui KM
Leuk Lymphoma; 2003 Sep; 44(9):1457-62. PubMed ID: 14565644
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors.
Hayashi K; Hooper LC; Chin MS; Nagineni CN; Detrick B; Hooks JJ
J Gen Virol; 2006 Aug; 87(Pt 8):2161-2169. PubMed ID: 16847112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
